Business Context and Reporting Period
Company: Weis Markets, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 28, 2009
Operations: The company operates 154 retail food stores in Pennsylvania and four surrounding states, plus 27 SuperPetz pet supply stores. It reports as a single segment.
Key Financial Metrics
| Metric | Q1 2009 | Q1 2008 |
|---|---|---|
| Net Sales | $606.2 million | $595.7 million |
| Gross Profit | $163.6 million | $152.7 million |
| Gross Margin | 27.0% | 25.6% |
| Operating Income | $25.1 million | $12.1 million |
| Operating Margin | 4.1% | 2.0% |
| Net Income | $16.5 million | $9.1 million |
| Earnings Per Share (Diluted) | $0.61 | $0.34 |
| Cash from Operations | $54.9 million | $47.9 million |
| Cash and Equivalents (End of Period) | $99.8 million | $63.3 million |
| Capital Expenditures | $8.2 million | $18.0 million |
Liquidity & Debt: The company holds $99.8 million in cash and cash equivalents. Outstanding letters of credit totaled $31.9 million. The filing does not disclose long-term debt balances in the provided text.
Material Changes vs. Prior Period
- Profitability Surge: Net income increased 82.4% year-over-year, driven by a 107.3% increase in operating income.
- Margin Expansion: Gross margin improved by 140 basis points (27.0% vs. 25.6%) due to a 39.3% reduction in inventory shrink and lower diesel fuel costs (down 13.9%).
- Expense Control: Operating, general, and administrative (OG&A) expenses decreased 1.5% to $138.4 million, representing 22.8% of sales compared to 23.6% in the prior year.
- Capital Discipline: Capital expenditures dropped significantly to $8.2 million (1.4% of sales) from $18.0 million (3.0% of sales) in the prior year.
- Comparable Sales: Comparable store sales increased 1.6%, while total sales rose 1.8%.
Outlook, Commentary, and Risks
- Promotional Strategy: The "Price Freeze" program on 2,400 staple items was extended for an additional 90 days and expanded to 3,000 items. This drove a 4.1% increase in average transaction size but a 2.0% decrease in store visits.
- Pharmacy & Dairy: Pharmacy sales were flat due to generic penetration and mail-order shifts. Dairy sales decreased 2.6% due to product deflation; management anticipates a 4.0% decline for the full year.
- Cost Outlook: Management expects health care benefit costs to increase approximately 7.7% in future quarters. Fuel usage is estimated to be reduced by 6.0% due to operational efficiencies.
- Capital Plan: The company estimates a total investment of approximately $80.5 million for 2009 capital expansion, funded by internal cash flows.
- Risks: Risks include general economic conditions, competitive pressures from retailers with greater financial resources, and fluctuating fuel prices.
Investor Verification Checklist
- Verify the sustainability of the 39.3% improvement in inventory shrink rates.
- Monitor the impact of the extended "Price Freeze" on gross margins in subsequent quarters.
- Confirm the trajectory of pharmacy sales given the headwinds from generic drug penetration.
- Review the full-year capital expenditure plan ($80.5 million) against the reduced Q1 spend.
- Assess the potential for rising health care costs to offset other operating expense reductions.